Skip to content

Pain Management Following Total Hip Arthroplasty

Postoperative Pain Management Following Total Hip Arthroplasty. A Comparison Between Local Infiltration Analgesia and Ultrasound Guided 3-in-1 Block

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02568995
Acronym
FEMORALIA
Enrollment
55
Registered
2015-10-06
Start date
2014-05-31
Completion date
2016-09-30
Last updated
2016-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain Intensity, Rescue Pain Requirements

Keywords

postoperative pain, morphine, total hip arthroplasty, femoral nerve block

Brief summary

Total hip arthroplasty (THA) is a common and standardized procedure. Postoperative mortality after hip joint replacement is low but some complications remain, including chronic post-surgical pain (1), hip dislocation (2), infection (3), and deep vein thrombosis (4). Strategies that have been identified to reduce morbidity and mortality include: posterior surgical approach, mechanical and pharmacological prophylaxis of deep vein thrombosis, and the use of spinal anesthesia (5). One of the important factors for patient satisfaction with lower limb arthroplasty is good postoperative pain management (6). Poorly managed postoperative pain can lead to chronic post-surgical pain and therefore aggressive postoperative pain management is important (7). Several different methods have been used to treat postoperative pain following THA. Recently, local infiltration analgesia (LIA) using a combination of large volume local anesthetics (LA) and non-steroidal anti-inflammatory agents (NSAID) injected systematically peri-articularly has been used for pain management with variable success (8). We found that better analgesia could be achieved when using LIA compared to intrathecal morphine during the first few days postoperatively (9,10). Ultrasound techniques are commonly used for peripheral nerve blocks and have been shown to reduce pain intensity and may be considered by many to be a standard of care. Specifically, the 3-in-1 block has been commonly used because of its ease of application and good pain management following total hip arthroplasty. The present study aims to compare postoperative pain intensity following local infiltration analgesia with a standardised 3-in-1 block for total hip arthroplasty.

Detailed description

Sixty ASA I-II patients undergoing THA would be randomised to one of two groups in a double-blind study: Group LIA: A total of 151.5 ml of a combination of 0.2% ropivacaine (150 ml), 30 mg ketorolac (1 ml) and 0.5 mg (0.5 ml) adrenaline was administered systematically peri-articularly during THA and 30 ml of normal saline for ultrasound-guided 3-in-1 block Group Femoral block: Received 30 ml of ropivacaine 0,75% for ultrasound-guided 3-in-1 block and a total of 151.5 ml of normal saline peri-articularly. All patients would receive spinal anaesthesia with 0.5% heavy bupivacaine for surgery Postoperatively, the following parameters would be measured: 1. Pain intensity at fixed time intervals during 0-7 days and thereafter at weekly intervals for 1 month 2. Rescue morphine consumption during 0-4, 4-24 and 24-48 h 3. Side effects and complications 4. Home readiness and length of hospital stay 5. Chronic pain intensity measured after 3 and 6 months using the Brief Pain Inventory 6. Plasma Cytokine concentration at fixed intervals 7. Motor block using Bromage scale 8. EQ5D and HOOS questionnaires

Interventions

DRUGropivacaine + ketorolac + adrenaline

A combination of drugs injected locally for postoperative pain management

Sponsors

Örebro University, Sweden
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* 40-80 years * ASA I-II * THA operation

Exclusion criteria

* Chronic pain requiring opiates * Language constraints preventing completion of the study * Contraindications to regional block

Design outcomes

Primary

MeasureTime frameDescription
Pain intensity24 hPain intensity during movement at 24 h after end of surgery

Secondary

MeasureTime frameDescription
Rescue analgesic consumption0-24 hAmount of PCA morphine used for pain management
Chronic pain3-6 monthsPain at 3 and 6 months after surgery using Brief Pain Inventory
InflammationPreoperative to 3-5 days postoperativelyPre- and post-operative cytokine concentration would be measured

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026